Feng Lifeng, Ma Yanning, Sun Jie, Shen Qi, Liu Leiming, Lu Haiqi, Wang Faliang, Yue Yongfang, Li Jiaqiu, Zhang Shenjie, Lin Xiaoying, Chu Jue, Han Weidong, Wang Xian, Jin Hongchuan
Laboratory of Cancer Biology; Sir Runrun Shaw Hospital; School of Medicine; Zhejiang University; Hangzhou, Zhejiang China.
Department of Medical Oncology; Institute of Clinical Science; Sir Runrun Shaw Hospital; School of Medicine; Zhejiang University; Hangzhou, Zhejiang Province China.
Autophagy. 2014 Aug;10(8):1442-53. doi: 10.4161/auto.29486. Epub 2014 Jun 11.
Autophagy is a self-proteolytic process that degrades intracellular material to enable cellular survival under unfavorable conditions. However, how autophagy is activated in human carcinogenesis remains largely unknown. Herein we report an epigenetic regulation of autophagy in human cancer cells. YY1 (YY1 transcription factor) is a well-known epigenetic regulator and is upregulated in many cancers. We found that YY1 knockdown inhibited cell viability and autophagy flux through downregulating SQSTM1 (sequestosome 1). YY1 regulated SQSTM1 expression through the epigenetic modulation of the transcription of MIR372 (microRNA 372) which was found to target SQSTM1 directly. During nutrient starvation, YY1 was stimulated to promote SQSTM1 expression and subsequent autophagy activation by suppressing MIR372 expression. Similar to YY1 depletion, MIR372 overexpression blocked autophagy activation and inhibited in vivo tumor growth. SQSTM1 upregulation and competent autophagy flux thus contributed to the oncogenic function of YY1. YY1-promoted SQSTM1 upregulation might be a useful histological marker for cancer detection and a potential target for drug development.
自噬是一种自我蛋白水解过程,可降解细胞内物质,使细胞在不利条件下存活。然而,自噬在人类致癌过程中如何被激活在很大程度上仍不清楚。在此,我们报告了人类癌细胞中自噬的表观遗传调控。YY1(YY1转录因子)是一种著名的表观遗传调节因子,在许多癌症中上调。我们发现,YY1敲低通过下调SQSTM1(sequestosome 1)抑制细胞活力和自噬通量。YY1通过对MIR372(microRNA 372)转录的表观遗传调控来调节SQSTM1表达,发现MIR372可直接靶向SQSTM1。在营养饥饿期间,YY1被刺激通过抑制MIR372表达来促进SQSTM1表达及随后的自噬激活。与YY1缺失类似,MIR372过表达阻断自噬激活并抑制体内肿瘤生长。因此,SQSTM1上调和有效的自噬通量有助于YY1的致癌功能。YY1促进的SQSTM1上调可能是癌症检测的有用组织学标志物和药物开发的潜在靶点。